Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1415)
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,373
Price
$276.17
Total Value
$655.34K
Shares Held After
73,293
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
9,430
Price
$275.45
Total Value
$2.60M
Shares Held After
75,666
% of Holdings
11.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$480.31
Total Value
$1.12M
Shares Held After
37,734
% of Holdings
5.8%
JOHNSON & JOHNSON (JNJ)
Decker Robert J — VP Corporate Controller
Shares
4,075
Price
$247.87
Total Value
$1.01M
Shares Held After
23,682
% of Holdings
14.7%
NovoCure Limited (NVCR)
Weinberg Uri — Chf Medical and Innovation Ofr
Shares
7,461
Price
$13.84
Total Value
$103.26K
Shares Held After
213,757
% of Holdings
3.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
3,325
Price
$27.95
Total Value
$92.93K
Shares Held After
143,678
% of Holdings
2.3%
NovoCure Limited (NVCR)
Puri Michal Nath — Chief Human Resources Officer
Shares
1,441
Price
$13.66
Total Value
$19.69K
Shares Held After
162,322
% of Holdings
0.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
182,891
Price
$15.99
Total Value
$2.92M
Shares Held After
2,276,354
% of Holdings
7.4%
Cardinal Health, Inc. (CAH)
Greene Michelle D. — Chief Information Officer
Shares
2,646
Price
$228.47
Total Value
$604.53K
Shares Held After
12,230
% of Holdings
17.8%
Cardinal Health, Inc. (CAH)
Greene Michelle D. — Chief Information Officer
Shares
100
Price
$228.55
Total Value
$22.86K
Shares Held After
14,876
% of Holdings
0.7%
Option Care Health, Inc. (OPCH)
Bavaro Michael — Chief Human Resources Officer
Shares
6,000
Price
$33.00
Total Value
$198.00K
Shares Held After
33,249
% of Holdings
15.3%
Option Care Health, Inc. (OPCH)
Pate R Carter — Director
Shares
30,287
Price
$32.05
Total Value
$970.62K
Shares Held After
11,623
% of Holdings
72.3%
NovoCure Limited (NVCR)
Paravasthu Mukund — Chief Operating Officer
Shares
1,555
Price
$13.66
Total Value
$21.25K
Shares Held After
76,751
% of Holdings
2.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,761
Price
$45.72
Total Value
$171.97K
Shares Held After
10,503
% of Holdings
26.4%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,739
Price
$45.13
Total Value
$168.76K
Shares Held After
14,264
% of Holdings
20.8%
HARROW, INC. (HROW)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$54.18
Total Value
$270.90K
Shares Held After
65,000
% of Holdings
7.1%
NovoCure Limited (NVCR)
Leonard Frank X — Chief Executive Officer
Shares
9,734
Price
$13.66
Total Value
$133.00K
Shares Held After
338,011
% of Holdings
2.8%
NovoCure Limited (NVCR)
Leupin Nicolas — Former Chief Medical Officer
Shares
1,029
Price
$13.66
Total Value
$14.06K
Shares Held After
104,079
% of Holdings
1.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
1,725
Price
$496.95
Total Value
$857.24K
Shares Held After
98,278
% of Holdings
1.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
5,995
Price
$496.16
Total Value
$2.97M
Shares Held After
100,003
% of Holdings
5.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
15,580
Price
$495.38
Total Value
$7.72M
Shares Held After
105,998
% of Holdings
12.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
3,498
Price
$494.33
Total Value
$1.73M
Shares Held After
121,578
% of Holdings
2.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,520
Price
$493.29
Total Value
$1.24M
Shares Held After
125,076
% of Holdings
2.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
949
Price
$491.30
Total Value
$466.24K
Shares Held After
127,596
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,725
Price
$490.54
Total Value
$1.34M
Shares Held After
128,545
% of Holdings
2.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
460
Price
$489.32
Total Value
$225.09K
Shares Held After
131,270
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
3,278
Price
$488.27
Total Value
$1.60M
Shares Held After
131,730
% of Holdings
2.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,510
Price
$487.13
Total Value
$1.22M
Shares Held After
135,008
% of Holdings
1.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
240
Price
$482.84
Total Value
$115.88K
Shares Held After
137,518
% of Holdings
0.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
120
Price
$481.50
Total Value
$57.78K
Shares Held After
137,758
% of Holdings
0.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
400
Price
$479.75
Total Value
$191.90K
Shares Held After
137,878
% of Holdings
0.3%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
400
Price
$10.86
Total Value
$4.34K
Shares Held After
22,006
% of Holdings
1.8%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
10,900
Price
$67.84
Total Value
$739.50K
Shares Held After
7,465
% of Holdings
59.4%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
14,584
Price
$67.08
Total Value
$978.28K
Shares Held After
18,365
% of Holdings
44.3%
INTUITIVE SURGICAL INC (ISRG)
Widman Fredrik — VP Corporate Controller
Shares
249
Price
$499.71
Total Value
$124.43K
Shares Held After
909
% of Holdings
21.5%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,117
Price
$190.91
Total Value
$213.24K
Shares Held After
9,235
% of Holdings
10.8%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
100
Price
$145.71
Total Value
$14.57K
Shares Held After
642,308
% of Holdings
0.0%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
6,419
Price
$145.18
Total Value
$931.90K
Shares Held After
642,408
% of Holdings
1.0%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
3,481
Price
$144.04
Total Value
$501.39K
Shares Held After
648,827
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
140
Price
$334.39
Total Value
$46.81K
Shares Held After
22,129
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
942
Price
$332.48
Total Value
$313.20K
Shares Held After
22,269
% of Holdings
4.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
1,159
Price
$331.49
Total Value
$384.20K
Shares Held After
23,211
% of Holdings
4.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
2,259
Price
$330.73
Total Value
$747.12K
Shares Held After
24,370
% of Holdings
8.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
127
Price
$328.92
Total Value
$41.77K
Shares Held After
26,629
% of Holdings
0.5%
Jazz Pharmaceuticals plc (JAZZ)
RIEDEL NORBERT G — Director
Shares
3,415
Price
$192.00
Total Value
$655.68K
Shares Held After
7,024
% of Holdings
32.7%
INTUITIVE SURGICAL INC (ISRG)
Curet Myriam — EVP & Chief Medical Officer
Shares
2,345
Price
$499.71
Total Value
$1.17M
Shares Held After
409
% of Holdings
85.1%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
7,697
Price
$25.05
Total Value
$192.81K
Shares Held After
172,909
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
Olian Judy D. — Director
Shares
200
Price
$509.55
Total Value
$101.91K
Shares Held After
4,845
% of Holdings
4.0%
LEMAITRE VASCULAR INC (LMAT)
Kamke Trent G — Senior V. P., Operations
Shares
1,044
Price
$110.29
Total Value
$115.14K
Shares Held After
6,677
% of Holdings
13.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Dunn Edmund — Principal Accounting Officer
Shares
25,164
Price
$18.10
Total Value
$455.51K
Shares Held After
22,693
% of Holdings
52.6%
Showing 1–50 of 1415 transactions (page 1 of 29)